Retinoic Acid Receptors in Ovarian Cancer Cells
Author Information
Author(s): H. Harant, I. Korschineck, G. Krupitzal, B. Fazeny, C. Dittrich, T.W. Grunt
Primary Institution: Universitaet Wien
Hypothesis
The study investigates the effects of retinoic acid and synthetic retinoids on the growth of human ovarian cancer cell lines and the expression of retinoic acid receptors.
Conclusion
Retinoic acid and synthetic retinoids can inhibit the growth of ovarian cancer cells, but the response is not directly linked to the presence of specific retinoic acid receptor transcripts.
Supporting Evidence
- Six out of seven ovarian adenocarcinoma cell lines showed growth inhibition when treated with retinoids.
- The ovarian teratocarcinoma cell line PA-1 did not respond to retinoids.
- All cell lines expressed RAR-alpha and RAR-gamma mRNA, while RAR-beta was not detected in some lines.
Takeaway
This study found that certain substances can slow down the growth of ovarian cancer cells, but not all cells respond the same way.
Methodology
The study used cell culture techniques, dose-response assays, and polymerase chain reaction to analyze the effects of retinoids on ovarian cancer cell lines.
Limitations
The study did not establish a direct association between receptor expression and growth response, and the qualitative nature of the RT-PCR analysis limits quantitative conclusions.
Want to read the original?
Access the complete publication on the publisher's website